UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 150

Sortiert nach

Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania

BMC public health, 2016-02, Vol.16 (185), p.182-182, Article 182

2016

Volltextzugriff (PDF)

Risky sexual practices among youth attending a sexually transmitted infection clinic in Dar es Salaam, Tanzania

BMC infectious diseases, 2008-11, Vol.8 (1), p.159-159, Article 159

2008

Volltextzugriff (PDF)

Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience

Tropical medicine & international health, 2009-10, Vol.14 (10), p.1226-1232

2009

Volltextzugriff (PDF)

Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods

Journal of immunological methods, 2003-06, Vol.277 (1), p.65-74

2003

Volltextzugriff (PDF)

Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam

Retrovirology, 2012-09, Vol.9 (S2), p.P153-P153, Article P153

2012

Volltextzugriff (PDF)

Molecular Characterization of Haemophilus ducreyi Isolates from Different Geographical Locations

Journal of Clinical Microbiology, 2006, Vol.44 (1), p.132-137

2006

Volltextzugriff (PDF)

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study

Journal of acquired immune deficiency syndromes (1999), 2009-11, Vol.52 (3), p.406

2009

Volltextzugriff (PDF)

Global trends in molecular epidemiology of HIV-1 during 2000-2007

AIDS (London), 2011-03, Vol.25 (5), p.679-689

2011

Volltextzugriff (PDF)

Affordable CD4 + T cell counts by flow cytometry : II. The use of fixed whole blood in resource-poor settings

Journal of immunological methods, 2001-11, Vol.257 (1), p.145-154

2001

Volltextzugriff (PDF)

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

Retrovirology, 2012-09, Vol.9 (S2), p.P108-P108, Article P108

2012

Volltextzugriff (PDF)

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

PloS one, 2015-04, Vol.10 (4), p.e0118486-e0118486

2015

Volltextzugriff (PDF)

Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study

Journal of acquired immune deficiency syndromes (1999), 2008-07, Vol.48 (3), p.315

2008

Volltextzugriff (PDF)

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA

Retrovirology, 2009-10, Vol.6 (S3), p.P403-P403, Article P403

2009

Volltextzugriff (PDF)

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

Vaccine, 2011-10, Vol.29 (46), p.8417-8428

2011

Volltextzugriff (PDF)

AIDS: An International Perspective

Science (American Association for the Advancement of Science), 1988-02, Vol.239 (4840), p.573-579

1988

Volltextzugriff (PDF)

P14-03. HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P191-P191, Article P191

2009

Volltextzugriff (PDF)

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers

AIDS research and human retroviruses, 2017-08, Vol.33 (8), p.880

2017

Volltextzugriff (PDF)

Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara

The Journal of infectious diseases, 2008-11, Vol.198 (10), p.1482-1490

2008

Volltextzugriff (PDF)

Gender aspects on HIV prevention efforts and participation in HIV vaccine trials among Police officers in Dar es Salaam, Tanzania

BMC public health, 2018-07, Vol.18 (1), p.905-905, Article 905

2018

Volltextzugriff (PDF)

Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination

Journal of immunological methods, 1996-09, Vol.195 (1), p.103-112

1996

Volltextzugriff (PDF)

Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania

PloS one, 2014-03, Vol.9 (3), p.e90938-e90938

2014

Volltextzugriff (PDF)

Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania

Journal of acquired immune deficiency syndromes (1999), 2000-04, Vol.23 (5), p.410

2000

Volltextzugriff (PDF)

Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania

PloS one, 2011-02, Vol.6 (2), p.e14619-e14619

2011

Volltextzugriff (PDF)

Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania

International journal of STD & AIDS, 1998-02, Vol.9 (2), p.104

1998

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(148)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania

Risky sexual practices among youth attending a sexually transmitted infection clinic in Dar es Salaam, Tanzania

Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience

Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods

Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam

Molecular Characterization of Haemophilus ducreyi Isolates from Different Geographical Locations

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study

Global trends in molecular epidemiology of HIV-1 during 2000-2007

Affordable CD4 + T cell counts by flow cytometry : II. The use of fixed whole blood in resource-poor settings

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study

P14-14 LB. A low dose of multigene, multiclade HIV DNA given intradermally induces strong and broad immune responses after boosting with heterologous HIV MVA

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

AIDS: An International Perspective

P14-03. HIV-specific T-lymphocyte proliferative responses induced by a multigene multiclade HIV-1 DNA/MVA heterologous vaccine in Tanzanian volunteers

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers

Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara

Gender aspects on HIV prevention efforts and participation in HIV vaccine trials among Police officers in Dar es Salaam, Tanzania

Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination

Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania

Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania

Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania

Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania

Suchergebnisse filtern